Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12609000434291
Ethics application status
Approved
Date submitted
12/05/2009
Date registered
10/06/2009
Date last updated
3/06/2011
Type of registration
Retrospectively registered

Titles & IDs
Public title
Long-Term follow up of Hodgkin Lymphoma Survivors: An Australian and New Zealand Patterns of Care Study
Scientific title
Researcher survey assessment of the variability in current patterns of care and current and potential surveillance strategies for treatment-related late effects of Hodgkin Lymphoma Survivors: An Australian and New Zealand Patterns of Care Study
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Hodgkin Lymphoma 4761 0
Condition category
Condition code
Cancer 237099 237099 0 0
Hodgkin's

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Once only online survey to invited researchers by professional group (Haematologist and Oncologist). If agree to participate in this study, then it is required that the online survey is completed, it takes 15minutes
Intervention code [1] 4537 0
Not applicable
Comparator / control treatment
NO CONTROL
Control group
Uncontrolled

Outcomes
Primary outcome [1] 5931 0
Collection of long term follow up data. Data such as overall survival, development of second cancer will be collected via the survery
Timepoint [1] 5931 0
to be distribute to select clinicians May 2009 - July 2009
Secondary outcome [1] 242024 0
Establish patterns of care. Collection of data from the questionnaire will inform current patterns of care practiced by clinicians
Timepoint [1] 242024 0
May 2009 - July 2009

Eligibility
Key inclusion criteria
Australasian Leukaemia and Lymphoma Group member clinician treating Hodgkin Lymphoma
Minimum age
N/A
Maximum age
N/A
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
not applicable, the clinician (haematologist and oncologist) must be invited to participate in this survey.

Study design
Purpose
Duration
Longitudinal
Selection
Defined population
Timing
Retrospective
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Date of first participant enrolment
Anticipated
8/05/2009
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
100
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 4948 0
Self funded/Unfunded
Name [1] 4948 0
Country [1] 4948 0
Primary sponsor type
Other Collaborative groups
Name
Australasian Leukaemia and Lymphoma Group (ALLG)
Address
Level 2
10 St Andrews Place
East Melbourne
3002
Country
Australia
Secondary sponsor category [1] 4467 0
None
Name [1] 4467 0
Address [1] 4467 0
Country [1] 4467 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 7046 0
Sydney South West Area Health Service Human Research Ethics Committee
Ethics committee address [1] 7046 0
Liverpool Hospital
Elizabeth St, Liverpool
NSW, 2170
Ethics committee country [1] 7046 0
Australia
Date submitted for ethics approval [1] 7046 0
Approval date [1] 7046 0
Ethics approval number [1] 7046 0

Summary
Brief summary
To describe current patterns of care of ‘long-term’ *survivors of Hodgkin
lymphoma across Australia and New Zealand.
* For the purposes of this study, we have defined ‘long-term survivors’ as those
patients who are five years or more after their primary diagnosis of lymphoma
Trial website
Australasian Leukaemia and Lymphoma Group Website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 29595 0
Address 29595 0
Country 29595 0
Phone 29595 0
Fax 29595 0
Email 29595 0
Contact person for public queries
Name 12842 0
Eng-Siew Koh
Address 12842 0
Dr Eng-Siew Koh
Radiation Oncology
Liverpool Hospital
Elizabeth St, Liverpool
NSW, 2170
Country 12842 0
Australia
Phone 12842 0
+61 2 9828 6541
Fax 12842 0
+61 2 9828 6670
Email 12842 0
[email protected]
Contact person for scientific queries
Name 3770 0
Eng-Siew Koh
Address 3770 0
Dr Eng-Siew Koh
Radiation Oncology
Liverpool Hospital
Elizabeth St, Liverpool
NSW, 2170
Country 3770 0
Australia
Phone 3770 0
+61 2 9828 6541
Fax 3770 0
+61 2 9828 6670
Email 3770 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.